Ruiying Gong
Ruiying Gong has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Bin Chen
Department of Critical Care Medicine, Third Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming Municipal Hospital of Traditional Chinese Medicine, China
1 shared publication- Gege Dong
Qilu University of Technology (Shandong Academy of Sciences)
1 shared publication - Jinping Li
School of Information Science and Engineering, University of Jinan, Jinan 250022, China
1 shared publication Minghui Tie
Department of Critical Care Medicine, Third Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming Municipal Hospital of Traditional Chinese Medicine, China
1 shared publicationQing Xie
Department of Rehabilitation Medicine, Affiliated Hospital of Guizhou Medical University, China
1 shared publication- Qingbo Yang
School of Mathematics and Statistics, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250353, P. R. China
1 shared publication
Latest Publications
- 29 March 2023
- Published by Springer Nature
- p. 893-901
Information Aggregation and Fuzzy Decision Making Based on Vague Set Theory
- 29 March 2023
- Published by Springer Nature
- p. 893-901
Information Aggregation and Fuzzy Decision Making Based on Vague Set Theory
- RetractedOpen Access
- 11 July 2022
- Published by Wiley in Computational and Mathematical Methods in Medicine
- Vol. 2022, 1-8
Effects of Shenling Chengqi Decoction on Gastrointestinal Function and Immune Status of Patients with Gastrointestinal Injury in Severe Sepsis
Objective. To investigate the effects of Shenling Chengqi decoction combined with routine treatment on gastrointestinal function and immune status of patients with gastrointestinal injury in severe sepsis. Methods. 160 patients with sepsis were randomly divided into a control group ( ) and observation group ( ). The control group was given routine treatment such as anti-infection and vasoactive drugs. The observation group was treated with Shenling Chengqi decoction on the basis of routine treatment for 7 days. The improvement of gastrointestinal symptoms, nutritional status, gastrointestinal dynamics, inflammatory response, and immune function was observed before and after treatment. The outcome indicators were evaluation of gastrointestinal symptoms, evaluation of disease severity, nutritional status, gastrointestinal dynamic indexes, inflammatory indexes, and immune function indexes. SPSS 22.0 statistical software was used for data processing. The paired -test was used for comparison before and after treatment. Results. Compared with the control group, the disappearance time of reflux, vomiting, and recovery time of bowel sounds in the observation group were significantly shorter ( ), and the number of defecation per day was significantly higher than that in the control group ( ). After 3 and 7 days of treatment, the APACHE II score, SIRS score, serum gas, IgA, IgM, serum hs-CRP, TNF, and PCT of the two groups were significantly lower than those before treatment ( ), and the scores of the observation group were significantly lower than those of the control group ( ). The levels of SS and MOT were significantly higher than those before treatment ( ). After 7 days of treatment, the levels of serum Hb, ALB, and PA in the two groups were significantly higher than those before treatment ( ), and the nutritional status in the observation group was significantly higher than that in the control group ( ). Conclusion. Shenling Chengqi decoction can effectively improve gastrointestinal symptoms, nutritional status, and gastrointestinal dynamics in patients with sepsis. It has high safety and is worthy of clinical promotion.
- 11 July 2022
- Published by Wiley in Computational and Mathematical Methods in Medicine
- Vol. 2022, 1-8
RetractedOpen AccessEffects of Shenling Chengqi Decoction on Gastrointestinal Function and Immune Status of Patients with Gastrointestinal Injury in Severe Sepsis
Objective. To investigate the effects of Shenling Chengqi decoction combined with routine treatment on gastrointestinal function and immune status of patients with gastrointestinal injury in severe sepsis. Methods. 160 patients with sepsis were randomly divided into a control group ( ) and observation group ( ). The control group was given routine treatment such as anti-infection and vasoactive drugs. The observation group was treated with Shenling Chengqi decoction on the basis of routine treatment for 7 days. The improvement of gastrointestinal symptoms, nutritional status, gastrointestinal dynamics, inflammatory response, and immune function was observed before and after treatment. The outcome indicators were evaluation of gastrointestinal symptoms, evaluation of disease severity, nutritional status, gastrointestinal dynamic indexes, inflammatory indexes, and immune function indexes. SPSS 22.0 statistical software was used for data processing. The paired -test was used for comparison before and after treatment. Results. Compared with the control group, the disappearance time of reflux, vomiting, and recovery time of bowel sounds in the observation group were significantly shorter ( ), and the number of defecation per day was significantly higher than that in the control group ( ). After 3 and 7 days of treatment, the APACHE II score, SIRS score, serum gas, IgA, IgM, serum hs-CRP, TNF, and PCT of the two groups were significantly lower than those before treatment ( ), and the scores of the observation group were significantly lower than those of the control group ( ). The levels of SS and MOT were significantly higher than those before treatment ( ). After 7 days of treatment, the levels of serum Hb, ALB, and PA in the two groups were significantly higher than those before treatment ( ), and the nutritional status in the observation group was significantly higher than that in the control group ( ). Conclusion. Shenling Chengqi decoction can effectively improve gastrointestinal symptoms, nutritional status, and gastrointestinal dynamics in patients with sepsis. It has high safety and is worthy of clinical promotion.